Skip to main content
Live

Market Intelligence

Page 125

Stocks·ai

Tech Sector’s $650 Billion AI Binge: Are Investors Right to Doubt the Hyperscaler Frenzy?

Feb 8, 2026·8m
Stocks·hang-seng

Hong Kong’s Hang Seng at a Standstill: Is the Silence Before the Storm in Asian Equities?

Feb 8, 2026·8m
Stocks·sp500

S&P 500’s K-Shaped Rally: Why Wall Street’s Great Divide Is Only Getting Wider

Feb 7, 2026·8m
Stocks·dow-jones

Dow 50,000: Why Wall Street's Old Guard Is Suddenly Back in Style as Tech Stalls

Feb 7, 2026·8m
Stocks·sp500-equal-weight

S&P 500 Equal Weight Index Hits All-Time High as Wall Street’s Great Divide Deepens

Feb 7, 2026·8m
Stocks·ai

AI Hype Hangover: Are Software Stocks Facing a Lost Year as Investors Rotate to Old Economy Plays?

Feb 7, 2026·8m
Stocks·ai

NYSE’s AI Trade Jitters: Why Wall Street Is Suddenly Second-Guessing the Tech Boom

Feb 7, 2026·8m
Stocks·healthcare

Big Pharma’s Earnings Flex: Why Healthcare Is Quietly Outmuscling Wall Street’s Hottest Trades

Feb 7, 2026·8m
Stocks·xlk

Tech ETF XLK Goes Nowhere as Wall Street’s AI Obsession Hits a Wall

Feb 7, 2026·8m
Stocks·dow-jones

Dow 50,000: Old-Economy Stocks Upstage Tech as Wall Street’s Great Rotation Accelerates

Feb 7, 2026·8m
Stocks·sp500

S&P 500’s Relentless Grind: Has the Index’s 6,900 Plateau Become the New Normal?

Feb 7, 2026·8m
Stocks·ai

AI’s $650 Billion Hangover: Why Wall Street Is Suddenly Betting Against the Tech Spending Spree

Feb 7, 2026·8m
Stocks·market-breadth

S&P 500’s K-Shaped Rally: Why Market Breadth Is the Only Metric That Matters in 2026

Feb 7, 2026·8m
Stocks·big-pharma

Obesity Wars and Patent Cliffs: Big Pharma’s Earnings Blowout Masks a Brewing Storm

Feb 7, 2026·8m
Stocks·sp500-equal-weight

S&P 500 Equal Weight Index Hits All-Time High as Market Rotation Reshapes the Playbook

Feb 7, 2026·8m